Bionano Genomics, Inc. (BNGO)
1.00
-0.04
(-3.85%)
USD |
NASDAQ |
Nov 13, 16:00
1.01
+0.01
(+1.00%)
After-Hours: 19:59
Bionano Genomics Enterprise Value : 11.38M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 11.38M |
| November 12, 2026 | 11.92M |
| November 11, 2026 | 12.73M |
| November 10, 2026 | 14.49M |
| November 09, 2026 | 13.54M |
| November 06, 2026 | 13.41M |
| November 05, 2026 | 12.73M |
| November 04, 2026 | 13.95M |
| November 03, 2026 | 14.08M |
| November 02, 2026 | 13.54M |
| October 30, 2026 | 13.41M |
| October 29, 2026 | 14.08M |
| October 28, 2026 | 14.15M |
| October 27, 2026 | 14.36M |
| October 26, 2026 | 13.54M |
| October 23, 2026 | 13.14M |
| October 22, 2026 | 13.81M |
| October 21, 2026 | 14.76M |
| October 20, 2026 | 14.69M |
| October 19, 2026 | 14.36M |
| October 16, 2026 | 14.76M |
| October 15, 2026 | 16.38M |
| October 14, 2026 | 16.38M |
| October 13, 2026 | 16.25M |
| October 12, 2026 | 16.04M |
| Date | Value |
|---|---|
| October 09, 2026 | 17.26M |
| October 08, 2026 | 17.60M |
| October 07, 2026 | 17.60M |
| October 06, 2026 | 17.46M |
| October 05, 2026 | 17.39M |
| October 02, 2026 | 17.87M |
| October 01, 2026 | 19.08M |
| September 30, 2026 | 18.95M |
| September 29, 2026 | 16.66M |
| September 28, 2026 | 16.07M |
| September 25, 2026 | 15.83M |
| September 24, 2026 | 16.19M |
| September 23, 2026 | 16.31M |
| September 22, 2026 | 17.72M |
| September 21, 2026 | 17.84M |
| September 18, 2026 | 16.66M |
| September 17, 2026 | 16.78M |
| September 16, 2026 | 14.07M |
| September 15, 2026 | 14.66M |
| September 14, 2026 | 11.95M |
| September 11, 2026 | 10.65M |
| September 10, 2026 | 10.42M |
| September 09, 2026 | 10.18M |
| September 08, 2026 | 10.42M |
| September 04, 2026 | 10.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.24B |
| Bio-Rad Laboratories, Inc. | 9.549B |
| Bruker Corp. | 11.01B |
| Danaher Corp. | 186.02B |
| Harvard Bioscience, Inc. | 82.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.453M |
| Revenue (Quarterly) | 8.276M |
| Total Expenses (Quarterly) | 14.73M |
| EPS Diluted (Quarterly) | -0.5382 |
| Gross Profit Margin (Quarterly) | 47.72% |
| Profit Margin (Quarterly) | -77.97% |
| Earnings Yield | -267.6% |
| Normalized Earnings Yield | -260.05 |